Successful unconventional precision treatment of inflammatory hormone receptor-positive breast cancer guided by molecular profiling
Crossref DOI link: https://doi.org/10.1038/s41698-025-00845-5
Published Online: 2025-03-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Elayoubi, Jailan
Zong, Yu
Schwartz, Erich J.
Text and Data Mining valid from 2025-03-07
Version of Record valid from 2025-03-07
Article History
Received: 5 November 2024
Accepted: 22 February 2025
First Online: 7 March 2025
Competing interests
: The authors declare no competing interests.